The Home of the Life Sciences Industry

Search

Explore Latest News

grandbrothers/Shutterstock

Eli Lilly's Antibody Combo Wins FDA Approval for Mild to Moderate COVID-19

This combination therapy has been authorized for the treatment of mild to moderate COVID-19 in patients aged 12 and older who are at high risk for progressing to severe COVID-19 and/or hospitalization.
Michael Vi / Shutterstock

GIlead's O'Day's Gamble on Galapagos is Facing Headwinds

Belgium-based Galapagos NV and Foster City, California-based Gilead Sciences halted the ISABELA Phase III clinical trial of ziritaxestat in idiopathic pulmonary fibrosis.
Copyright © 2009-2020 Merck Sharp & Dohme Corp., a

FDA Adcom Gives Merck’s Keytruda a Surprise Thumbs Down

BigHat BioScience’s founders – CEO Mark DePristo a

BigHat Plans to Take Antibody Engineering to a Whole New Level

Kate Krav-Rude/Shutterstock

AbbVie, Caribou Biosciences Collaborate in $40 Million CAR-T Cell Deal

View more news

2021 Hotbeds

See the booming life sciences regions and who's hiring.

 

Featured Employers

View all employers

View all Featured Employers

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.

Email jobs

Employers

Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now